Оценка клинико-экономической эффективности лечения шизофрении атипичными антипсихотиками пролонгированного действия в инъекционной форме с учетом приверженности пациентов к терапии

Омельяновский Виталий Владимирович, Авксентьева Мария Владимировна, Ивахненко Оксана Игоревна et al. · Социальная и клиническая психиатрия · 2012

Injectable depot antipsychotics happen to be a promising dir ection in the treatment of schizophrenia, also because they help to solve the problem of compliance. The goal of this investigation was clinical and economic evaluation of two atypical antipsychotics: paliperidone palmitate and risperidone depot. In the used mathematical model, the authors studied the effects of lower frequency of drug administration on the treatment outcome from both clinical and economic perspectives in the course of one year. The economic evaluation was based on cost minimization analysis. The researchers conclude: though the antipsychotics studied have similar clinical effi cacy and safety characteristics, the use of paliperidone palmitate (Xeplion) is associated with lower costs than in using risperidone (Rispolept Consta) due to pat ients less frequent visits to outpatient and polyclinical services, their better compliance and lower relapse rate.

Cited by 0 works.

Authors